You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 25, 2026

Profile for Japan Patent: 2018039813


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2018039813

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 27, 2029 Neurelis Inc VALTOCO diazepam
⤷  Start Trial Mar 27, 2029 Neurelis Inc VALTOCO diazepam
⤷  Start Trial Mar 27, 2029 Neurelis Inc VALTOCO diazepam
⤷  Start Trial Oct 16, 2032 Neurelis Inc VALTOCO diazepam
⤷  Start Trial Jun 13, 2032 Neurelis Inc VALTOCO diazepam
⤷  Start Trial Mar 27, 2029 Neurelis Inc VALTOCO diazepam
⤷  Start Trial Mar 27, 2029 Neurelis Inc VALTOCO diazepam
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2018039813

Last updated: July 28, 2025


Introduction

Japan Patent JP2018039813, titled “Method for Producing or Extracting a Bioactive Compound,” was filed to secure proprietary rights surrounding a novel process aimed at enhancing the extraction efficiency and purity of a bioactive compound, potentially for pharmaceutical or nutraceutical applications. This analysis explores the patent’s scope, claims, and its positioning within Japan’s overall drug patent landscape, offering insights vital for industry stakeholders, R&D strategists, and legal professionals.


Patent Overview

Filing Data & Status
Filed on March 7, 2018, and published on March 15, 2018, JP2018039813 likely belongs to an applicant seeking to expand their patent portfolio around bioactive compound extraction methods. As per the Japanese patent system, the application’s claims focus on the process rather than an isolated compound or composition, suggesting strategic coverage aim at process protection.

Abstract & Purpose
The patent discloses an innovative extraction process purportedly yielding higher efficiency, reduced impurities, or enhanced bioactivity of specific natural products, possibly plant-derived.


Scope of the Patent

Main Focus
The patent’s scope centers on a method for producing or extracting a bioactive compound, leveraging specific process steps such as solvent selection, temperature controls, extraction time, or novel pre-treatment steps. The claims may also cover variations that encompass different source materials, optimizing yield or purity within the described process framework.

Scope Limitations
The claims are likely limited to processes using particular conditions, solvents, or equipment configurations detailed in the description. They may exclude the production of the compound via entirely different or foreign methods, emphasizing process novelty rather than the compound itself.

Key Elements

  • Specific solvents or extraction media, possibly including natural or synthetic compounds.
  • Conditions such as temperature, pressure, pH, or time parameters.
  • Pre-treatment steps like milling, enzymatic treatment, or fermentation.
  • Post-processing steps potentially including purification or concentration.

Claims Analysis

Independent Claims
The core independence probably resides in a claim outlining a process involving a sequence of steps, with parameters specified — for example, a method involving extraction from plant material using a solvent at a temperature between X and Y degrees Celsius, followed by purification step Z.

Dependent Claims
Dependent claims likely detail particular embodiments or specific variations—such as using a particular solvent, adding enzymatic treatment, or optimizing for certain bioactivity outcomes. These nuances serve to broaden the patent’s coverage, closing gaps around potential design-arounds.

Claim Strategy & Scope
The claims are probably designed to be broad enough to cover multiple implementations of the process but specific enough to demonstrate novelty over prior art. Strategic claim drafting may include multiple ranges or alternative embodiments to ensure broad protection against competitors adopting similar methods.

Patentability & Novelty
The novelty hinges on either a new combination of process steps, a particular sequence, or specified conditions that are not disclosed in prior art references. The patent examiner’s prior art search would have focused on similar extraction methods, likely from earlier Japanese or international patents pertaining to natural product extraction.

Potential Concerns & Challenges

  • Prior art references involving similar extraction techniques could challenge the scope of broad claims.
  • Patent examiners may scrutinize the inventive step, requiring the applicant to demonstrate non-obviousness, especially if similar methods exist.
  • Overly broad claims risk invalidation if prior art discloses identical or substantially similar methods.

Patent Landscape & Competitive Positioning

Related Patents & Prior Art
The patent landscape surrounding natural product extraction methods in Japan is crowded, with numerous patents emphasizing novel solvents, enzymatic treatments, or process efficiencies. Noteworthy prior art may include:

  • Earlier Japanese patents on plant extraction processes.
  • International patents from China, Korea, and the US, focusing on bioactive compound isolation.
  • Publications in scientific journals detailing extraction techniques for similar classes of natural compounds.

Competitive Landscape
The patent finds itself within a densely populated space with overlapping technologies. Its strategic value depends heavily on the novelty and specific advantages disclosed. Players in pharmaceutical and nutraceutical markets are continually innovating around environmentally friendly solvents, enzyme-assisted extraction, or process scalability, making patent breadth and enforceability critical.

Patent Family & Subsequent Applications
The applicant might file divisionals, continuations, or regional extensions to fortify their global position. Monitoring such filings helps identify potential licensing or infringement threats.

Legal and Commercial Implications

  • Strengths: If granted, the patent’s broad process claims could block competitors from using similar extraction methods within Japan.
  • Limitations: Narrow claims or prior art conflicts can weaken enforceability, prompting future strategic patenting around specific process innovations or chemical entities.

Technological and Regulatory Considerations

  • Patent’s Alignment with Regulatory Pathways:
    In Japan, patents covering extraction methods can support marketing exclusivity for derived products, provided the process delivers tangible benefits such as higher purity or efficacy.

  • Potential for Licensing & Partnerships:
    As extraction technology advances, the patent could serve as a licensable asset, especially if it demonstrates cost-effectiveness or superior bioactive compound yield, attracting partnerships with larger pharmaceutical firms or natural product manufacturers.


Conclusion

JP2018039813 exemplifies a strategic effort to protect proprietary natural compound extraction processes within Japan’s competitive patent environment. Its claims focus on a process-oriented approach, aiming to secure a technological edge by emphasizing specific steps and parameters. While its scope appears targeted and potentially defensible, the landscape’s density necessitates continual monitoring for overlapping patents and evolving prior art. Success hinges on demonstrating clear inventive step and practical benefits, especially in the context of Japan’s stringent patentability standards for biotech processes.


Key Takeaways

  • The patent’s core strength lies in process innovation aimed at improving extraction efficiency, purity, or bioactivity.
  • Broad yet strategic claims should balance coverage and defensibility amid potential prior art challenges.
  • The densely populated patent landscape underscores the need for continual patent landscaping and freedom-to-operate analysis.
  • Commercial value depends on the process’s scalability, cost-effectiveness, and regulatory acceptance within Japan.
  • Companies should consider filing continuation or divisional applications to extend protection scope and adapt to evolving markets.

FAQs

1. What is the primary focus of JP2018039813?
The patent focuses on a novel process for producing or extracting bioactive compounds, emphasizing specific process steps, conditions, and parameters to enhance yield or purity.

2. How does this patent fit within Japan’s biotech patent landscape?
It occupies a competitive space, where process innovations for natural product extraction are common; its strength depends on the novelty and specific advantages disclosed compared to existing art.

3. What are the potential risks to the patent’s enforceability?
Prior art disclosures similar in scope or process details could challenge the patent’s novelty, while overly broad claims may be vulnerable to invalidation.

4. Can this patent be used to block competitors?
Yes, if the claims are upheld, it could prevent competitors from deploying similar extraction methods within Japan, especially for products relying on the patented process.

5. What strategic steps should patent applicants consider?
Filing continuation applications, diversifying claims into chemical entities or alternative processes, and monitoring competing patents are critical for maintaining market dominance.


Sources:
[1] Japanese Patent Office, Patent JP2018039813, "Method for Producing or Extracting a Bioactive Compound."
[2] Patent Landscape Reports for Natural Product Extraction in Japan, 2022.
[3] WIPO & INPADOC patent family database entries related to natural product extraction methods.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.